Summary
The product Provimed 25, manufactured by Deus Medical, was analyzed to verify its composition and potency. The sample, identified by batch number DM08290 with a manufacturing date of October 2020, was tested by Janoshik Analytical, a laboratory recognized for its expertise in pharmaceutical quality analysis. The analysis confirmed the presence of Mesterolone, with measured concentrations of 24.54 mg in the first pill and 25.01 mg in the second pill. These values closely align with the labeled specification of 25 mg, with minimal variances of 1.84% below and 0.04% above the label claim, respectively. These findings demonstrate the product’s accurate dosing.
The testing process was initiated on 13 November 2020, with the sample received on 18 November 2020, and the analysis completed on 20 November 2020. As the sample was submitted and funded by the reseller, DeusPower.shop, the results warrant careful evaluation. This report is published to support educational purposes and harm reduction by providing consumers with insights into the quality and consistency of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Provimed 25
- Active Ingredient: Mesterolone
- Batch Number: DM08290
- Manufacture Date: October 2020
- Expiration Date: Not provided
- Delivery Method: Oral (pill)
Sample Acquisition and Testing
- Task Number: #09131
- Testing Ordered: 13 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DeusPower.shop (Reseller)
- Analysis Paid For By: DeusPower.shop (Reseller)
Testing Results
- Specification: 25 mg/pill (as stated on the label)
- Measured Concentration:
- First Pill: 24.54 mg (1.84% below the label claim)
- Second Pill: 25.01 mg (0.04% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/09131_E25IYSTQJK13
- Originally Published: https://thinksteroids.com/community/forums/analytical-lab-testing/
Evaluation of Reseller-Funded Testing
This analysis was funded and submitted by the reseller, DeusPower.shop, highlighting the importance of a critical interpretation of the results. Reseller-funded testing can involve selective sample submission, potentially influencing the findings. However, the credibility of Janoshik Analytical and their transparent reporting process provides confidence in the results. For further validation, cross-referencing with third-party or independent testing is recommended to confirm the consistency of product quality across multiple batches.
Conclusion
The analysis confirms that Provimed 25 by Deus Medical is accurately dosed, with concentrations measured at 24.54 mg and 25.01 mg per pill. These results align closely with the labeled specification, affirming the product’s reliability. This report offers valuable insights for harm reduction and educational purposes, encouraging consumers to make informed decisions. Further independent validation would enhance confidence in these results.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
